- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01003951
Acupuncture for the Treatment of Chronic Lymphedema
Acupuncture for the Treatment of Chronic Lymphedema: A Feasibility Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Memorial Sloan Kettering Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women age 18 or older willing to sign consent.
- Lymphedema in an arm as a result of surgery, chemotherapy, and/or radiation therapy for breast cancer per Breast surgeon or medical oncologist.
- Patients must have received a clinical diagnosis of lymphedema for at least 6 months and no more than 5 years after diagnosis of chronic lymphedema.
- The affected arm must be >2cm larger than the unaffected arm; this is the standard diagnosis and the one used in the MSKCC studies cited above. The standard measurement techniques will be applied 20.
Exclusion Criteria:
- Previous acupuncture treatment for lymphedema
- Diuretic use
- History of primary (congenital) lymphedema
- Metastatic cancer
- History of autoimmune disorder (including lupus, rheumatoid arthritis, systemic sclerosis)
- History of other fibroproliferative disorder including cirrhosis, pulmonary fibrosis, kidney fibrosis, systemic sclerosis/scleroderma
- Current treatment with corticosteroids
- Treatment with myelosuppressive or stimulatory drugs within 6 months of enrollment
- History of bone marrow transplantation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Acupuncture
Each patient will receive two acupuncture treatments each week for four consecutive weeks.
At the end of four weeks, the intervention will be complete.
|
Acupuncture treatments will be given at the Integrative Medicine Outpatient Center, if needed in particular cases, at the MSKCC Breast Center. Each treatment is 30-40 minutes in duration. Each patient will receive two acupuncture treatments each week for four consecutive weeks. Before and after each treatment, the circumference of the patient's upper arm, and forearm will be measured in both the affected and unaffected arms. The greater difference between affected and unaffected arms (either the forearm or the upper arm) for each patient will be used for outcome assessment. Photographs of the patient's affected and unaffected arms before and after each treatment will be taken to provide visual documentation of status. The patient's face will not appear in the photographs. Blood draws will be performed from the unaffected arm in serum collection tubes and will be performed within 1 week of starting acupuncture and within 1 week of completion of the 4 week protocol. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To obtain preliminary evidence of the effects of acupuncture on chronic lymphedema due to breast cancer treatment.
Time Frame: twice weekly for four consecutive weeks and will be followed for an additional 6 months
|
twice weekly for four consecutive weeks and will be followed for an additional 6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To further evaluate the safety of acupuncture in this setting.
Time Frame: 6 months to record any side effects that may occur post-treatment
|
6 months to record any side effects that may occur post-treatment
|
|
To obtain preliminary evidence of systemic immune changes that occur after acupuncture treatment of lymphedema.
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Barrie Cassileth, MD, Memorial Sloan Kettering Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 09-136
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.